Henry Schein is a major global distributor of products and services to office-based dental and medical practitioners. Its catalog spans consumables, equipment, software and practice-support services for dentists, physicians and veterinary customers in many countries. Scale in dental distribution, manufacturer relationships and value-added practice solutions differentiate it from single-category suppliers.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 3,240 | — | 86 | — |
| Q3 2025 | 3,339 | — | 101 | — |
| Q4 2025 | 3,437 | — | 101 | — |
| Q1 2026 | 3,368 | — | 107 | — |
| Q2 2026 | 3,458 | 6.7% | 94 | 9.3% |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: Cytokinetics, Incorporated (CYTK), Lineage, Inc. (LINE), Old National Bancorp (ONB), Praxis Precision Medicines, Inc. (PRAX), Kymera Therapeutics, Inc. (KYMR), ABIVAX Société Anonyme (ABVX)